Motesanib Plus Carboplatin/Paclitaxel in Patients With Advanced Squamous Non–Small-Cell Lung Cancer: Results From the Randomized Controlled MONET1 Study
Authors:
- Silvia NovelloSNSilvia Novello
- Giorgio V. ScagliottiGSGiorgio V. Scagliotti
- Oleksandr SydorenkoOSOleksandr Sydorenko
- Ihor VynnychenkoIVIhor Vynnychenko
- Constantin VolovatCVConstantin Volovat
- Claus-Peter SchneiderCSClaus-Peter Schneider
- Fiona BlackhallFBFiona Blackhall
- Sheryl McCoySMSheryl McCoy
- Yong-Jiang HeiYHYong-Jiang Hei
- David R. SpigelDSDavid R. Spigel
- 1 August 2014
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 9 (8) , 1154-1161
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Overall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)Annals of Oncology, 2010
- Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trialThe Lancet, 2009
- Phase III Trial of Cisplatin Plus Gemcitabine With Either Placebo or Bevacizumab As First-Line Therapy for Nonsquamous Non–Small-Cell Lung Cancer: AVAiLJournal of Clinical Oncology, 2009
- Randomized Phase II Study of Vandetanib Alone or With Paclitaxel and Carboplatin as First-Line Treatment for Advanced Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2008
- Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung CancerNew England Journal of Medicine, 2006
- Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung CancerJournal of Clinical Oncology, 2004
- Molecular mechanisms of angiogenesis in non‐small cell lung cancer, and therapeutics targeting related moleculesCancer Science, 2003
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002